1-1 of 1
Nicholas Heaney, MD
Close
Save search
Sort by
Journal Articles

Imatinib Followed by Reduced Intensity Stem Cell Transplantation and Donor Lymphocyte Infusions Is Effective in Chronic Phase CML with Less Toxicity Than Standard Allogeneic Transplantation.

Free
Mhairi Copland, MD, Nicholas Heaney, MD, Karen Stewart, BSc, Judith Godden, PhD, Graeme Smith, MD, Charles Crawley, MD, Tessa L. Holyoake, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1125.
https://doi.org/10.1182/blood.V106.11.1125.1125
Published: 2005